Summary.-Simultaneous measurement of neutrophil migration, phagocytic activity, candidacidal and bactericidal activity were made during quadruple chemotherapy of advanced Hodgkin's disease (HD). Measurements were also made in normal individuals, hospital patients not on chemotherapy, untreated patients with advanced HD and patients off chemotherapy for over a year.
Summary.-Simultaneous measurement of neutrophil migration, phagocytic activity, candidacidal and bactericidal activity were made during quadruple chemotherapy of advanced Hodgkin's disease (HD) . Measurements were also made in normal individuals, hospital patients not on chemotherapy, untreated patients with advanced HD and patients off chemotherapy for over a year.
Neutrophil migratory activity was usually normal in untreated HD patients and those on chemotherapy, but > 200O of all tests showed depressed values, some of which were corrected by plasma. Similar results were found with neutrophil phagocytosis. Abnormalities in these functions were found in both early and late cycles, but there was a tendency for migration to deteriorate during later chemotherapy cycles. Neutrophil candidacidal and bactericidal activity were frequently depressed in patients on treatment and there was deterioration in candidacidal activity during the chemotherapy cycle. These abnormalities of killing activity were frequently corrected in control plasma.
Neutrophil function is normal in most patients with advanced HD and in patients in remission. In a minority of patients on treatment there are marked functional defects, especially in killing activity. These defects are partly cell-associated and partly plasma-related. Susceptibility to infection during chemotherapy of HD may be partly due to defective neutrophil function.
PATIENTS WITH HODGKIN'S DISEASE (HD) are susceptible to infection both as a result of the disease and its treatment. Depression of cell-mediated immunity is a well recognised accompaniment of advanced disease (Aisenberg, 1971 ) which contributes to the susceptibility to virus infections, especially herpes zoster (Arvin et al., 1978) and opportunistic organisms.
Other mechanisms of host defence have been less well studied. Neutrophil function has been the subject of some investigation, but reported studies have usually concerned themselves with single aspects of neutrophil function, and have not always distinguished between the effects of Correspondence to Dr R. L. Souliami. disease and of treatment. Results have therefore been conflicting; neutrophil microbial-killing activity for example being reported as depressed (Lehrer & Cline, 1971) or normal (Steigbigel et al., 1976; Hancock et al., 1976) .
We have studied several white-cell functions simultaneously in patients with advanced HD over many cycles of combination chemotherapy. The aim has been to relate abnormalities in host defence function to clinical infection, and to attempt to develop a host defence "screen" capable of predicting the onset of infection in immune-compromised patients by simultaneous measurement of WBC num-bers and function. The present paper decribes neutrophil migratory, phagocytic and killing activity in HD and the effect of chemotherapy on these functions. The results of tests on monocyte functioin and leucocyte numbers performed at the same time will be reported separately.
METHODS
Preparation of leucocytes.-50 ml of blood w%Nas mixed with 10 ,ug/ml preservative-free heparin. A 3ml aliquot wsras mixed with Plasmasteril (Fresenius) in equal volume and left to stand for 20 min at room temperature. The leucocyte-rich supernatant was washed in a working medium consisting of antibioticfree RPM1 containing 01°o bovine serum albumin (BSA) and in 20mM HEPES. The cells were suspended at 2 x 106/ml and this suspension was used in all tests of neutrophil function. The average cell composition was 79-90o neutrophils, 12*6°lymphocytes, 7-5o monocytes for both controls and patients. All function tests were carried out in both autologous and control plasma. Control plasma was obtained from the normal control subject who was tested with each batch of samples. The small percentage of contaminating monocytes does not interfere w%ith the interpretation of the data. In the phagocytosis and killing assay, monocytes can be identified easily and are not scored. In the migration assay the pore size used for neutrophils does not admit monocytes, which in any event migrate more slowly and can be identified by nonspecific-esterase staining. Monocytes do not kill Pseudomonas significantly in the conditions used.
Neutrophil Pseudomonas killing. The method was a modification of that of Grogan & Miller (1973) . Pseudomonas aeruginosa was used at a final concentration of 106/ml. 041 ml of cells (2 x 106/ml), 0-2 ml of organisms and 0-05 ml of autologous or control plasma were mixed for 60 min at 37°C, followed by the addition of 0-1 ml of 2% sodium deoxycholate. 01 ml of the supernatant was then placed in 2-5 ml nutrient broth, plated on to McConkey agar plates, incubated overnight and the colonies then counted. Tests wAere carried out in duplicate, with control or autologous plasma, and 00 kill wAas determined by the reduction in colony count as compared with the same procedure in the absence of neutrophils.
Neutrophil Candida phagocytosis and killing. -We used a modification of the technique of Lehrer (1970) . C. guillermondii was the test organism. In preliminary experiments it wTas found that, although a ratio of 4 organisms to 1 neutrophil gave a higher phagocytic index, at this ratio the assessment of killing was difficult because of the distension of the cytoplasm with yeasts. Because wNe wished to combine measurement of phagocytosis and killing in the same test we chose a 2:1 ratio. Addison & Babbage (1976) . It is a membrane-migration technique allowing the simultaneous comparison of several samples. The tests were carried out in duplicate in both control and autologous plasma. The leading front was determined in microns, at 250 x magnification.
PATIENTS
Thirty-three patients were studied over a total of 72 treatment cycles. Since many patients had low cell counts, it was not possible to do all tests on every occasion. Nineteen patients off treatment for more than a year were also studied. All patients had histologically proven HD and were of advanced stage (IIIB or Statistical analysis.-For the analyses of variance, all variables were transformed by taking square roots before analysis, to stabilize variances. Differences between days of the cycle were examined using a 3-factor (patients, cycles within patients and days of the cycle) analysis of variance; differences between patients and between cycles were regarded as "random" effects, differences between days of the cycle as "fixed". Pairwise comparisons between the means of different days were made using the least significant difference (Snedecor & Cochran, 1967 
RESULTS

Migration
The results of the tests of neutrophil migration are shown in Fig. 1 However, in those individuals who were studied through more than one complete cycle, when the fall in migration from Day 1 to 8/14 in early cycles was compared with that in the later cycles there was a slight, but significant (P < 0.05) tendency to a more pronounced fall with the later cycle. There was a significant variation in the response of individual subjects during the cycle (subject x days interaction) some showing improvement, others no change, others a deterioration. There was no significant difference between the Day 1 means of patients who were studied in both early and late cycles (Table I) indicating no fall with repeated chemotherapy. In 13/32 cases in which migration in autologous plasma was reduced, it became normal on testing in control plasma (Table II) . In those tests where function was improved by control plasma, the values returned to a normal mean and range (Table III (Table V) .
Candida phagocytosis
The 2 control populations gave similar values for phagocytosis (Fig. 2) . The phagocytic index (PI) in patients on Day 1 of the cycle was slightly lower than in the control groups (P < 0-02). The mean value was further depressed (compared with control) on Days 8 and 14 (P < 0.001). This fall from Day 1 to 8/14 was statistically significant (P < 0-05). The analysis of variance, however, showed no significant change between Day 1 of the earliest cycle and Day 1 of the latest cycle (Table I) .
The low values of PI in some patients were in part due to plasma factors (Tables  II and III) . Five of 15 low PJs were improved by the addition of control plasma. This effect of plasma was found on each of the 3 test days.
Of the 8 untreated patients, 2 had a depressed PI, which was corrected in normal plasma in each case (Table IV) . Only 1 of the patients off treatment for a year had abnormal PI and this was not corrected by normal plasma (Table V) . 
Candida killing
The hospital control population had a slightly lower mean killing index than the normal controls (Fig. 3) . The values on Day 1 of the chemotherapy cycle were the same as in normal controls but the Day 8/14 values were depressed from 1-43 to 0-9 (P<0-001). The analysis of variance confirmed a significant variation of killing index in different days in the cycle (P<0-01). Plasma factors were involved in the abnormal killing in 8/23 observations (Tables II and III) . There was no correlation between the occurrence of plasma factors and the day of the chemotherapy cycle.
Relationship between Candida killing defects and phagocytosis
There was an association between Candida killing and Candida phagocytosis normal plasma had no effect. The effect of plasma on improving killing was therefore usually produced by improved PI.
Bactericidal activity
The results of the tests of killing activity ( Fig. 4) (Table II) . This correction occurred at all days of the cycle. As with the other function tests, the degree of improvement in control plasma was sufficient for the values to return to a normal mean and range (Table III) . There were no measurements made in untreated patients and patients off treatment. Earlv and late-cycle Day 1 values were the same (Table I) .
IDISCUSSION
Previous studies of neutrophil function in cancer patients have usually measured one function alone, and have usually failed to distinguish between the effects of chemotherapy and those of the disease. This study is the first to use multiple measurements of function in groups of patients who are untreated, or on chemotherapy, or who have completed treatment.
Neutrophil migration in patients with untreated HlD is usually normal, but a minority show depressed values. During chemotherapy also, the patients' neutrophils usually migrate normally but in some instances (-200 The phagocytic activity of neutrophils is also usually normal, but again a minority of untreated patients have defective phagocytosis, and we found a tendency, which was significant statistically, for chemotherapy to cause further impairment. Our observations are similar to those of Sbarra et al. (1964) , who found defective bacterial phagocytosis in neutrophils of lymphoma patients, and showed that this was often corrected by normal serum. We have also shown that plasma effects are responsible, at least in part, for defective phagocytosis of Candida in 5/15 patients on chemotherapy on the days both before and during drug treatment. It is not known whether the plasma effects are due to the presence of factors which inhibit phagocytosis or to absence of stimulating factors. On the other hand Lehrer & Cline (1971) found neutrophil phagocytosis to be normal in patients with HD on chemotherapy, but they used a lower Candida/cell ratio, which may have presented a lesser phagocytic challenge. Davies et al. (1976) have shown that cytotoxic agents can impair neutrophil phagocytosis in vitro and in patients on treatment.
There is proportionately a greater impairment of Candidacidal and bactericidal activity of neutrophils than of the other functions. In the case of Candida killing, the defect is related to chemotherapy, the neutrophils from most untreated patients being normal, as are those from patients off treatment. When the low Candida killing index was associated with defective phagocytosis, both abnormalities were usually corrected by control plasma. In contrast, when phagocytosis was normal, depressed killing was not affected by control plasma. This result demonstrates the importance of carrying out simultaneous measurements of phagocytosis and killing where possible. Defective Candida killing in these patients can therefore be a result either of defective phagocytosis related to plasma factors or of a cell-associated defect in the presence of normal phagocytosis.
Pseudonomas killing is markedly impaired during chemotherapy, and this effect is often attributable to plasma factors. This result confirms the finding of Sbarra (1964) but contradicts that of Steigbigel et al. (1976) and Hancock et al. (1976) , who found normal bactericidal activity. This discrepancy may be partly due to technical factors, since, in the experiments of Steigbigel et al., the tests were carried out using longer incubation with bacteria, and delay in phagocytosis and killing would not have been detected. This study therefore shows that patients with HD on chemotherapy usually have normal neutrophil migratory activity but phagocytic and killing activitY is frequently depressed. Although these defects are also found in a minority of untreated patients, the Candida phagocytic and killing defect worsens as the chemotherapy cycle proceeds. While circulating cytotoxic drugs may be responsible for some of the defects during the cycle, the nature of the plasma factors responsible for defective function on Day 1 of chemotherapy and in untreated patients is unknown. Defective neutrophil function may increase susceptibility to infection. particularly if more than one function is defective simultaneously in the same patient, as is the case with phagocytosis and killing. We have also shown that other aspects of host defence, such as monocyte function, are affected in these same patients and that severe lymphopenia develops during the treatment cycle. The relationship between defective neutrophil and monocyte function and leucocyte number and clinical infection will be reported separately. Defective neutrophil function may therefore be one component of a variety of host defence abnormalities which put HD patients with advanced disease at risk of infection during treatment.
